The effects of SHetA2 on molecular endpoints in cancer cells are much greater than its effects in healthy cells, which translates into the lack of observed toxicity [6, 7, 15, 18], however differential effects on cyclin D1 specifically have not yet been evaluated. This evidence concerns the gene CCND1 and cancer.